IL134791A0 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase - Google Patents

Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Info

Publication number
IL134791A0
IL134791A0 IL13479198A IL13479198A IL134791A0 IL 134791 A0 IL134791 A0 IL 134791A0 IL 13479198 A IL13479198 A IL 13479198A IL 13479198 A IL13479198 A IL 13479198A IL 134791 A0 IL134791 A0 IL 134791A0
Authority
IL
Israel
Prior art keywords
inhibitors
neutrophil elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
IL13479198A
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719189.4A external-priority patent/GB9719189D0/en
Priority claimed from GBGB9719183.7A external-priority patent/GB9719183D0/en
Priority claimed from GBGB9719290.0A external-priority patent/GB9719290D0/en
Priority claimed from GBGB9803611.4A external-priority patent/GB9803611D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL134791A0 publication Critical patent/IL134791A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
IL13479198A 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase IL134791A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9719189.4A GB9719189D0 (en) 1997-09-09 1997-09-09 New therapeutic method
GBGB9719183.7A GB9719183D0 (en) 1997-09-09 1997-09-09 Compounds
GBGB9719290.0A GB9719290D0 (en) 1997-09-10 1997-09-10 Compounds
GBGB9803611.4A GB9803611D0 (en) 1998-02-21 1998-02-21 Compounds
PCT/EP1998/005609 WO1999012933A2 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (1)

Publication Number Publication Date
IL134791A0 true IL134791A0 (en) 2001-04-30

Family

ID=27451698

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13479198A IL134791A0 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Country Status (24)

Country Link
EP (1) EP1003748A2 (en)
JP (1) JP2001515904A (en)
KR (1) KR20010023766A (en)
CN (1) CN1278820A (en)
AP (1) AP2000001761A0 (en)
AR (1) AR017072A1 (en)
AU (1) AU9741298A (en)
BR (1) BR9812062A (en)
CA (1) CA2303176A1 (en)
CO (1) CO4970719A1 (en)
EA (1) EA200000204A1 (en)
EE (1) EE200000138A (en)
HU (1) HUP0004644A3 (en)
ID (1) ID24452A (en)
IL (1) IL134791A0 (en)
IS (1) IS5391A (en)
MA (1) MA26543A1 (en)
NO (1) NO20001198L (en)
NZ (1) NZ503130A (en)
PE (1) PE107899A1 (en)
PL (1) PL339176A1 (en)
SK (1) SK3192000A3 (en)
TR (1) TR200000907T2 (en)
WO (1) WO1999012933A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
US7429659B2 (en) 2004-03-31 2008-09-30 Janssen Pharmaceutica N.V. Furan compounds as histamine H3 modulators
DE102004024772A1 (en) * 2004-05-17 2005-12-22 Grünenthal GmbH Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides
JP4853759B2 (en) * 2004-05-27 2012-01-11 日本農薬株式会社 Substituted pyrazinecarboxylic acid anilide derivatives or salts thereof, intermediates thereof, agricultural and horticultural agents, and methods of use thereof
TWI355380B (en) 2004-05-27 2012-01-01 Nihon Nohyaku Co Ltd Substituted pyrazinecarboxanilide derivatives or s
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
ATE439347T1 (en) 2004-11-23 2009-08-15 Warner Lambert Co 7-(2H-PYRAZOLE-3-YL)-3,5-DIHYDROXY-HEPTANIC ACID DERIVATIVES AS HMG-CO-A-REDUCTASE INHIBITORS FOR THE TREATMENT OF LIPIDEMIA
US8198288B2 (en) 2006-05-04 2012-06-12 Pulmagen Therapeutics (Inflammation) Limited Tetrahydropyrrolopyrimidinediones and their use in therapy
WO2007129060A1 (en) 2006-05-04 2007-11-15 Argenta Discovery Limited Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
US7662967B2 (en) 2007-08-02 2010-02-16 Cambridge Enterprise Limited Anti-inflammatory compounds and compositions
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
WO2009060206A1 (en) * 2007-11-07 2009-05-14 Argenta Discovery Limited 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
JP2023500182A (en) 2019-09-17 2023-01-05 メレオ バイオファーマ ４ リミテッド Alberestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome, and graft-versus-host disease
DK4106757T3 (en) 2020-04-16 2023-10-23 Mereo Biopharma 4 Ltd METHODS INVOLVING THE NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR THE TREATMENT OF AIRWAY DISEASE MEDIATED BY ALPHA-1-ANTITRYPSIN DEFICIENCY
CA3234399A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
PL329153A1 (en) * 1996-03-28 1999-03-15 Glaxo Group Ltd Derivatives of pyrrolopyrolone as inhibitors of neutropil elastase

Also Published As

Publication number Publication date
WO1999012933A2 (en) 1999-03-18
KR20010023766A (en) 2001-03-26
AU9741298A (en) 1999-03-29
HUP0004644A3 (en) 2002-01-28
MA26543A1 (en) 2004-12-20
AP2000001761A0 (en) 2000-03-31
EA200000204A1 (en) 2000-10-30
NO20001198D0 (en) 2000-03-08
BR9812062A (en) 2000-09-26
HUP0004644A2 (en) 2001-09-28
PE107899A1 (en) 1999-11-17
CO4970719A1 (en) 2000-11-07
ID24452A (en) 2000-07-20
AR017072A1 (en) 2001-08-22
JP2001515904A (en) 2001-09-25
CA2303176A1 (en) 1999-03-18
CN1278820A (en) 2001-01-03
NZ503130A (en) 2001-08-31
NO20001198L (en) 2000-05-08
SK3192000A3 (en) 2001-03-12
WO1999012933A3 (en) 1999-05-27
TR200000907T2 (en) 2000-11-21
PL339176A1 (en) 2000-12-04
EP1003748A2 (en) 2000-05-31
IS5391A (en) 2000-02-29
EE200000138A (en) 2001-02-15

Similar Documents

Publication Publication Date Title
IL125859A0 (en) Pyrrolopyrrolone derivatives useful as inhibitors of neutrophil elastase
IL141445A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
EP1004669A4 (en) Novel differentiation inhibitor
PL339173A1 (en) Derivatives of benzamidine as inhibitors of factor xa
PL339551A1 (en) Derivatives of rezorcin
HK1067124A1 (en) 2-phenyl-substituited imidazotriazinones as phoshodiesterase inhibitors
PL333918A1 (en) Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors
HUP0103349A3 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
EP1012139A4 (en) AZETIDINONE DERIVATIVES AS $g(b)-LACTAMASE INHIBITORS
PL337773A1 (en) Derivatives of benzimidazoles
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
AU3935895A (en) Alpha-ketoamide derivatives as cathepsin l inhibitor
IL134791A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
AU2274299A (en) Benzazine derivatives phosphodiesterase 4 inhibitors
IL139490A0 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
HUP9801991A3 (en) Proline derivatives useful as inhibitors of human leukocyte elastase
IL141446A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
HUP0003475A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
PL334769A1 (en) Derivatives of 5-aroylnaphtene
ZA985064B (en) Derivatives of pentaerythrits
ZA988160B (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
PL337875A1 (en) Derivatives of 6-azauracil as il-5 inhibitors
ID23866A (en) COMPOSITION FOR SAVING RICE AGAINST ACETLOCORS
PL338777A1 (en) Derivative of piperidinylmethyloxazolydinone
SI0891362T1 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase